Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount ...

Congress must fix the No Surprises Act before it bankrupts patients and employers, James Gelfand and Patricia Kelmar write.

A nationwide STAT survey of NIH-funded researchers reveals that, a year after Donald Trump's return to the White House, many ...

The Trump administration is weighing how to respond to a court ruling on vaccine policymaking, a decision that could come ...

The CDC had remarkable data on smoking rates last fall, but it no longer had smoking experts available to review it and ...

In Massachusetts, sepsis cases has more than tripled since 2010. Some blame hospitals' use of AI tools for medical coding and ...

Following successful appeals from drugmakers, the U.K. is taking another look at whether two new Alzheimer's drugs can be ...

The farm bill shows politicians catering to the agriculture industry risk losing the support of MAHA while running afoul of ...

Today's biotech news includes the Medicare director offering a tempered view of TrumpRx and high-dose Wegovy getting an FDA ...

A group of autism scientists kicked off efforts Thursday to influence Congress, and the research agendas of private ...

Cardiology groups say adults as young as 30 should assess cholesterol risk and consider treatment to prevent heart attacks ...

Democrats are laying out their plans to rebuild the health care system in the hopes of eventually regaining control of ...